Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1982-11-12
1985-01-22
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546200, 546223, A61K 31445, C07D40104
Patent
active
044951949
ABSTRACT:
Novel phthalimide intermediates are reduced to 5-sulfamoyl-6-halo-3-oxoisoindole compounds bearing a substituted 1-phenylalkyl-4-piperidinyl moiety as the isoindole N-substituent. Preferred compounds such as 6-chloro-2,3-dihydro-3-oxo-2-[1-(phenylmethyl)-4-piperidinyl]-1H-isoindole -5-sulfonamide exhibit diuretic and antihypertensive properties.
REFERENCES:
patent: 3579524 (1971-05-01), Van Dyke
Topliss, J., J. Med. Chem., 15, (10), 1006, (1972).
Cornish, E., et al., J. Pharm. Pharmac., 18, 65-80, (1966).
Chemical Abstracts, 81: 58265d, (1974), [Suzuki et al., Nippon Yakurigaku Zasshi, 1972, 68, (3), 276-89].
Chemical Abstracts, 90: 97589t, (1979), [Himori et al., Jpn. J. Pharmacol., 1978, 28, (6), 811-18].
Dolak Terence M.
Martin Tellis A.
Mead Johnson & Company
Ryan Richard P.
Schwartz Richard A.
Uloth Robert H.
LandOfFree
Antihypertensive isoindole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antihypertensive isoindole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antihypertensive isoindole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-566657